ابحث واعثر على CMO / CDMO الذي تحتاجه

المواد الخاضعة للرقابة: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, High potential for abuse & no medical use, Lower potential for abuse

الأسواق: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), MFDS (South Korea), EDE (UAE), TGA (Australia)

خدمات: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

منطقة: أوروبا

امتثال: FDA (cGMP), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), NMPA (China GMP), EMA (EU GMP), MFDS/KFDA (Republic of Korea GMP)

حجم الدفعة: Large, Small, Medium

يستخدم: Human, Veterinary

مجالات الخبرة العلاجية (ATC): (C) Cardiovascular system, (D) Dermatologicals, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (A) Digestive tract and metabolism

الفئة / المنتج: FDF / المنتجات الدوائية

OEB (نطاقات التعرض المهني): 1 / low-hazard (PDE > 10,000 µg/day)

المواد الخاضعة للرقابة: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, High potential for abuse & no medical use, Lower potential for abuse

الأسواق: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), ANVISA (Brazil), Russian Health Authorities, MHRA (UK), MFDS (South Korea), TGA (Australia)

منطقة: أوروبا

امتثال: FDA (cGMP), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), NMPA (China GMP), EMA (EU GMP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)

يستخدم: Human

خدمات: Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

مجالات الخبرة العلاجية (ATC): (C) Cardiovascular system, (D) Dermatologicals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (N) Nervous system, (A) Digestive tract and metabolism

OEB (نطاقات التعرض المهني): 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

حجم الدفعة: Small, Medium

الفئة / المنتج: FDF / المنتجات الدوائية

OEB (نطاقات التعرض المهني): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)

BSL (مستوى السلامة البيولوجية): 3, 4, 1, 2

المواد الخاضعة للرقابة: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse

الأسواق: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), MFDS (South Korea), TGA (Australia)

منطقة: أوروبا

امتثال: FDA (cGMP), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), TGA (Australia GMP), NMPA (China GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)

حجم الدفعة: Large, Small, Medium

يستخدم: Human, Veterinary

خدمات: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

مجالات الخبرة العلاجية (ATC): (H) Systemic hormonal preparations excl. sex hormones and insulins, (L) Antineoplastic and immunomodulating agents, (G) Genito urinary system and sex hormones

الفئة / المنتج: FDF / المنتجات الدوائية

الأسواق: EMA (EU), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), ANMAT (Argentina), INVIMA (Colombia)

خدمات: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging

منطقة: أوروبا

امتثال: BRCGS, ISO, IFS, World Health Organization (GMP / HACCP)

حجم الدفعة: Large, Small, Medium

الفئة / المنتج: مستحضرات التجميل, المغذيات

يستخدم: Human

مجالات الخبرة العلاجية (ATC): (V06) Nutrients

OEB (نطاقات التعرض المهني): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day)

BSL (مستوى السلامة البيولوجية): 3, 4

المواد الخاضعة للرقابة: High potential for abuse & medical use

امتثال: ICH, ISO, ANVISA (Brazil B-GMP), TITCK (Turkish Health Authorities), SFDA (Saudi Food & Drug Authority), NMPA (China GMP), EMA (EU GMP)

الأسواق: EMA (EU), NMPA (China), ANVISA (Brazil), MHRA (UK), SFDA (Saudi Arabia), Turkish Health Authorities

خدمات: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging

منطقة: أوروبا

حجم الدفعة: Large, Small, Medium

يستخدم: Human

مجالات الخبرة العلاجية (ATC): (L) Antineoplastic and immunomodulating agents

الفئة / المنتج: FDF / المنتجات الدوائية